Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T81888 |
mAChR antagonist 1
|
||
mAChRagonist 1 (compound 4a) 作为mAChR拮抗剂,其Ki值对M1、M3、M4及M5亚型分别为255 nM 、121 nM 、158 nM 和255 nM 。 | |||
T5655 |
mAChR-IN-1 hydrochloride
|
AChR | Neuroscience |
mAChR-IN-1 hydrochloride 是一种毒蕈碱胆碱能受体抑制剂,IC50值为17nM。 | |||
T14345 |
Atropine methyl bromide
甲溴阿托品,Methylatropine bromide |
AChR | Neuroscience |
Atropine methyl bromide (Methylatropine bromide) is a quaternary ammonium salt of atropine, characterized as a muscarinic receptor (mAChR) antagonist. It functions as a mydriatic to dilate the pupil during ophthalmic examination. Compared to atropine, it demonstrates reduced penetration into the central nervous system[1][2]. Its high polarity makes it particularly effective in relieving pyloric spasm in infants. | |||
T5476 |
mAChr-in-1
|
AChR | Neuroscience |
mAChR-IN-1 是一种毒蕈碱胆碱能受体拮抗剂,IC50为17 nM。 | |||
T61228 |
Pirenzepine
|
||
Pirenzepine (LS 519 free base) is a selective antagonist of the M1 muscarinic acetylcholine receptor (mAChR). It effectively inhibits gastric acid secretion and reduces muscle spasm, making it a valuable compound for investigating peptic ulcers. Additionally, Pirenzepine exhibits anti-proliferative activity against cancer cells [1] [2]. | |||
T60577 |
Cycrimine
|
||
Cycrimine 是毒蕈碱胆碱能受体(mAChR)M1的口服活性拮抗剂,可降低帕金森模型中乙酰胆碱的水平。Cycrimine 具有解痉活性,可用于研究行为和精神障碍。 | |||
T80477 |
Muscarinic toxin 3
MT3 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Muscarinic toxin 3 (MT3) 是高效的非竞争性mAChR及adrenoceptors拮抗剂,对M1、M4、α1A、α1B、α1D、α2A、α2B、α2C受体展示出不同程度的选择性,其pIC50值分别为6.71、8.79、8.86、7.57、8.13、8.49、6.5、7.29。该化合物具有显著的肾上腺素受体抑制活性。 | |||
T79618 |
M3/PDE4 modulator-1
|
||
M3/PDE4 modulator-1 (10f) 为多功能化合物,具备M3mAChR拮抗和PDE4抑制作用。于OVA大鼠模型中,M3/PDE4 modulator-1 (10-1000 nM/kg;iv) 能降低半胱氨酸嗜酸性粒细胞内流。 | |||
T74988 |
DIBA-Cy5
|
||
DIBA-Cy5 是一种 DIBA 荧光拮抗剂,由 DIBA-炔结合 Cyanine5 荧光团 (Cy5) 和聚乙二醇 (PEG) 生物分子组成。DIBA-Cy5 可以作为荧光配体,适合通过点击化学附着探针。DIBA-Cy5 对 type-2mAChR(M2R) 具有很高的结合亲和力 ( Kd=1.80 nM),可直接染色小鼠窦房结的 M2R 受体。 | |||
T73272 |
VU6019650
|
||
VU6019650 是一种强效、选择性的M5mAChR 正向拮抗剂 (IC50=36 nM),能够用于减轻阿片类药物使用障碍 (OUD) 的研究。VU6019650 具有血脑透过性,可能调节中边缘多巴胺能奖赏回路。VU6019650 能够阻断Oxotremorine M iodide 诱导引起的腹侧被盖区中脑 (VTA) 多巴胺神经元的放电速率的增加。 |